Filed: 5/15/2025ACC: 0001172661-25-002331
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 32 equity positions with a total reported market value of $188.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
32
Positions
$188.80M
Total AUM (reported)
43.34M
Total Shares
Allocation by class
COM$118.70M62.9%
COM NEW$26.85M14.2%
SPONSORED ADS$17.08M9.0%
SPONSORED ADR$7.79M4.1%
SPON ADS$7.10M3.8%
CL A ORD SHS$4.22M2.2%
CLASS A ORD SHS$4.09M2.2%
Portfolio Concentration
Top 3$37.94M20.1%
4–10$63.63M33.7%
11–25$72.85M38.6%
Rest$14.37M7.6%
Top 3 weight
20.1%
Top 10 weight
53.8%
Voting Authority Distribution
Total shares with voting rights: 43.34M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
43.34M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole32
Shared0
Other0
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings32
Rows:
CYTOKINETICS INC
SOLEShares370K
TypeSH
Market value$14.87M
7.88%
Sole
0.00
Shared
370K
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.01M
TypeSH
Market value$11.71M
6.20%
Sole
0.00
Shared
1.01M
None
0.00
EVOLUS INC
SOLEShares944.74K
TypeSH
Market value$11.37M
6.02%
Sole
0.00
Shared
944.74K
None
0.00
ABIVAX SA
SOLEShares1.64M
TypeSH
Market value$10.24M
5.42%
Sole
0.00
Shared
1.64M
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$10.11M
5.35%
Sole
0.00
Shared
750K
None
0.00
MERUS N V
SOLEShares237.16K
TypeSH
Market value$9.98M
5.29%
Sole
0.00
Shared
237.16K
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares4.97M
TypeSH
Market value$9.55M
5.06%
Sole
0.00
Shared
4.97M
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares245.27K
TypeSH
Market value$8.23M
4.36%
Sole
0.00
Shared
245.27K
None
0.00
ASCENDIS PHARMA A/S
SOLEShares50K
TypeSH
Market value$7.79M
4.13%
Sole
0.00
Shared
50K
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares595.88K
TypeSH
Market value$7.73M
4.09%
Sole
0.00
Shared
595.88K
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares250K
TypeSH
Market value$7.54M
4.00%
Sole
0.00
Shared
250K
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares1.81M
TypeSH
Market value$6.41M
3.40%
Sole
0.00
Shared
1.81M
None
0.00
IMMUNOVANT INC
SOLEShares375K
TypeSH
Market value$6.41M
3.39%
Sole
0.00
Shared
375K
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares10.98M
TypeSH
Market value$6.31M
3.34%
Sole
0.00
Shared
10.98M
None
0.00
NEUROGENE INC
SOLEShares470.96K
TypeSH
Market value$5.51M
2.92%
Sole
0.00
Shared
470.96K
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$4.99M
2.64%
Sole
0.00
Shared
275K
None
0.00
SUMMIT THERAPEUTICS INC
SOLEShares250K
TypeSH
Market value$4.82M
2.55%
Sole
0.00
Shared
250K
None
0.00
LEGEND BIOTECH CORP
SOLEShares138.24K
TypeSH
Market value$4.69M
2.48%
Sole
0.00
Shared
138.24K
None
0.00
VAXCYTE INC
SOLEShares115.52K
TypeSH
Market value$4.36M
2.31%
Sole
0.00
Shared
115.52K
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares2.73M
TypeSH
Market value$4.23M
2.24%
Sole
0.00
Shared
2.73M
None
0.00
HELIX ACQUISITION CORP II
SOLEShares373.83K
TypeSH
Market value$4.22M
2.24%
Sole
0.00
Shared
373.83K
None
0.00
ZURA BIO LTD
SOLEShares3.17M
TypeSH
Market value$4.09M
2.17%
Sole
0.00
Shared
3.17M
None
0.00
BEAM THERAPEUTICS INC
SOLEShares175.56K
TypeSH
Market value$3.43M
1.82%
Sole
0.00
Shared
175.56K
None
0.00
ARCELLX INC
SOLEShares45K
TypeSH
Market value$2.95M
1.56%
Sole
0.00
Shared
45K
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares1.27M
TypeSH
Market value$2.87M
1.52%
Sole
0.00
Shared
1.27M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 370K | SH | $14.87M 7.88% | 0.00 | 370K | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.01M | SH | $11.71M 6.20% | 0.00 | 1.01M | 0.00 |
EVOLUS INCSOLE | COM | 944.74K | SH | $11.37M 6.02% | 0.00 | 944.74K | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.64M | SH | $10.24M 5.42% | 0.00 | 1.64M | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 750K | SH | $10.11M 5.35% | 0.00 | 750K | 0.00 |
MERUS N VSOLE | COM | 237.16K | SH | $9.98M 5.29% | 0.00 | 237.16K | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 4.97M | SH | $9.55M 5.06% | 0.00 | 4.97M | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 245.27K | SH | $8.23M 4.36% | 0.00 | 245.27K | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 50K | SH | $7.79M 4.13% | 0.00 | 50K | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 595.88K | SH | $7.73M 4.09% | 0.00 | 595.88K | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 250K | SH | $7.54M 4.00% | 0.00 | 250K | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 1.81M | SH | $6.41M 3.40% | 0.00 | 1.81M | 0.00 |
IMMUNOVANT INCSOLE | COM | 375K | SH | $6.41M 3.39% | 0.00 | 375K | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 10.98M | SH | $6.31M 3.34% | 0.00 | 10.98M | 0.00 |
NEUROGENE INCSOLE | COM | 470.96K | SH | $5.51M 2.92% | 0.00 | 470.96K | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 275K | SH | $4.99M 2.64% | 0.00 | 275K | 0.00 |
SUMMIT THERAPEUTICS INCSOLE | COM | 250K | SH | $4.82M 2.55% | 0.00 | 250K | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 138.24K | SH | $4.69M 2.48% | 0.00 | 138.24K | 0.00 |
VAXCYTE INCSOLE | COM | 115.52K | SH | $4.36M 2.31% | 0.00 | 115.52K | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 2.73M | SH | $4.23M 2.24% | 0.00 | 2.73M | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 373.83K | SH | $4.22M 2.24% | 0.00 | 373.83K | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 3.17M | SH | $4.09M 2.17% | 0.00 | 3.17M | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 175.56K | SH | $3.43M 1.82% | 0.00 | 175.56K | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 45K | SH | $2.95M 1.56% | 0.00 | 45K | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 1.27M | SH | $2.87M 1.52% | 0.00 | 1.27M | 0.00 |
Page 1 of 2